Originally published in our sister publication, Pain Medicine News.
The FDA has granted breakthrough device designation to EaseVRx (AppliedVR) for the treatment of resistant fibromyalgia and chronic intractable lower back pain. The designation was based in part on a randomized controlled trial of the device evaluating the feasibility, efficacy and acceptability of virtual reality (VR)-based digital behavioral therapy for self-management of chronic pain at home.
The researchers, led by Beth